Cargando…

Comparison of Lamotrigine and Oxcarbazepine Monotherapy Among Chinese Adult Patients With Newly-Diagnosed Focal-Onset Epilepsy: A Prospective Observational Study

OBJECTIVE: We performed a prospective cohort study to compare the efficacy, safety, effect on mood, and quality of life between lamotrigine (LTG) and oxcarbazepine (OXC) monotherapy among Chinese adult patients with newly-diagnosed focal-onset epilepsy (FOE) with or without secondarily generalized t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuncan, Wang, Qinyue, Xu, Ye, Wu, Dongyan, Xu, Lan, Zhu, Guoxing, Wu, Xunyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226306/ https://www.ncbi.nlm.nih.gov/pubmed/35756921 http://dx.doi.org/10.3389/fneur.2022.855498

Ejemplares similares

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)

Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)

Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
por: Zhao, Fen, et al.
Publicado: (2023)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
por: Zhao, Binyang, et al.
Publicado: (2022)

Comparison of Cognitive Effects of Lamotrigine and Oxcarbazepine in Epilepsy Patients
por: Seo, Jong-Geun, et al.
Publicado: (2007)

Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open‐label, randomized study
por: Zhu, Haoyue, et al.
Publicado: (2022)

EEG-Driven Prediction Model of Oxcarbazepine Treatment Outcomes in Patients With Newly-Diagnosed Focal Epilepsy
por: Wang, Bin, et al.
Publicado: (2022)

Lamotrigine monotherapy for newly diagnosed typical absence seizures in children()
por: Holmes, Gregory L., et al.
Publicado: (2008)

Effect of Oxcarbazepine on Language Function in Patients With Newly Diagnosed Pediatric Epilepsy
por: Han, Min Jeong, et al.
Publicado: (2023)

Efficacy and tolerability of eslicarbazepine acetate as monotherapy in patients of newly diagnosed focal epilepsy
por: Saxena, S., et al.
Publicado: (2021)

Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
por: Liu, Wan-Ting, et al.
Publicado: (2020)

Effects of Lamotrigine on Problem-Solving Abilities in Newly Diagnosed Pediatric Patients with Epilepsy
por: Lee, Soo Hyun, et al.
Publicado: (2020)

Spectrum of Electroencephalography Findings in Newly Diagnosed Epilepsy
por: Khalily, Muhammad A, et al.
Publicado: (2021)

Lamotrigine as monotherapy in clinical practice: efficacy of various dosages in epilepsy
por: Warshavsky, Anton, et al.
Publicado: (2016)

Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes
por: Suo, Gui-hai, et al.
Publicado: (2021)

The clinical features of familial focal epilepsy with variable foci and NPRL3 gene variant
por: Wang, Yue, et al.
Publicado: (2023)

Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
por: Tartara, Elena, et al.
Publicado: (2022)

Anxiety and Depression in Newly Diagnosed Epilepsy: A Matter of Psychological History?
por: Forthoffer, Natacha, et al.
Publicado: (2021)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Yamamoto, Takamichi, et al.
Publicado: (2020)

Effect of clinical features on antiseizure medication doses in patients with newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2023)

Action Tremor Associated with Lamotrigine Monotherapy
por: Yang, Ji-Hye, et al.
Publicado: (2010)

Adjunctive Treatment With Eslicarbazepine Acetate for Adults and Children With Focal-Onset Epilepsy: A Meta-Analysis
por: Fei, Yanqing, et al.
Publicado: (2022)

Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study
por: Trinka, Eugen, et al.
Publicado: (2020)

The effect of lamotrigine on epilepsy
por: Ebrahimi, Hossein Ali, et al.
Publicado: (2012)

Glymphatic system function in patients with newly diagnosed focal epilepsy
por: Lee, Dong Ah, et al.
Publicado: (2022)

One-Year Analysis of Risk Factors Associated With Cognitive Impairment in Newly Diagnosed Epilepsy in Adults
por: Li, Nan, et al.
Publicado: (2020)

The Relationship Between Sleep, Cognition and Behavior in Children With Newly-Diagnosed Epilepsy Over 36 Months
por: Oyegbile-Chidi, Temitayo, et al.
Publicado: (2022)

Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2022)

Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy
por: Huber‐Mollema, Yfke, et al.
Publicado: (2019)

Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
por: Werz, Mary Ann
Publicado: (2008)

Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy
por: Lindauer, Andreas, et al.
Publicado: (2017)

Episodic Memory Dysfunction and Effective Connectivity in Adult Patients With Newly Diagnosed Nonlesional Temporal Lobe Epilepsy
por: Bakhtiari, Aftab, et al.
Publicado: (2022)

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
por: Marson, Anthony, et al.
Publicado: (2021)

Impact of diagnostic delay on seizure outcome in newly diagnosed focal epilepsy
por: Parviainen, Laura, et al.
Publicado: (2020)

Effect of Oxcarbazepine on Background EEG Activity and Cognition in Epilepsy
por: Kim, Sung Min, et al.
Publicado: (2013)

Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy
por: Berghuis, Bianca, et al.
Publicado: (2021)

Simultaneous Determination of Lamotrigine, Oxcarbazepine, Lacosamide, and Topiramate in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
por: Qiu, Erjie, et al.
Publicado: (2022)

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
por: Mari, Luisa, et al.
Publicado: (2021)

Efficacy and tolerability of lamotrigine in the treatment of focal epilepsy among children and adolescents: a meta-analysis
por: Ji, Lang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f5t42dr1cjj8d7b6ud1hgk5nsl